Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep;49(9):5819-5829.
doi: 10.1002/mp.15853. Epub 2022 Jul 25.

A multi-modality physical phantom for mimicking tumor heterogeneity patterns in PET/CT and PET/MRI

Affiliations

A multi-modality physical phantom for mimicking tumor heterogeneity patterns in PET/CT and PET/MRI

Alejandra Valladares et al. Med Phys. 2022 Sep.

Abstract

Background: Hybrid imaging (e.g., positron emission tomography [PET]/computed tomography [CT], PET/magnetic resonance imaging [MRI]) helps one to visualize and quantify morphological and physiological tumor characteristics in a single study. The noninvasive characterization of tumor heterogeneity is essential for grading, treatment planning, and following-up oncological patients. However, conventional (CONV) image-based parameters, such as tumor diameter, tumor volume, and radiotracer activity uptake, are insufficient to describe tumor heterogeneities. Here, radiomics shows promise for a better characterization of tumors. Nevertheless, the validation of such methods demands imaging objects capable of reflecting heterogeneities in multi-modality imaging. We propose a phantom to simulate tumor heterogeneity repeatably in PET, CT, and MRI.

Methods: The phantom consists of three 50-ml plastic tubes filled partially with acrylic spheres of S1: 1.6 mm, S2: 50%(1.6 mm)/50%(6.3 mm), or S3: 6.3-mm diameter. The spheres were fixed to the bottom of each tube by a plastic grid, yielding one sphere free homogeneous region and one heterogeneous (S1, S2, or S3) region per tube. A 3-tube phantom and its replica were filled with a fluorodeoxyglucose (18F) solution for test-retest measurements in a PET/CT Siemens TPTV and a PET/MR Siemens Biograph mMR system. A number of 42 radiomic features (10 first order and 32 texture features) were calculated for each phantom region and imaging modality. Radiomic features stability was evaluated through coefficients of variation (COV) across phantoms and scans for PET, CT, and MRI. Further, the Wilcoxon test was used to assess the capability of stable features to discriminate the simulated phantom regions.

Results: The different patterns (S1-S3) did present visible heterogeneity in all imaging modalities. However, only for CT and MRI, a clear visual difference was present between the different patterns. Across all phantom regions in PET, CT, and MR images, 10, 16, and 21 features out of 42 evaluated features in total had a COV of 10% or less. In particular, CONV, histogram, and gray-level run length matrix features showed high repeatability for all the phantom regions and imaging modalities. Several of repeatable texture features allowed the image-based discrimination of the different phantom regions (p < 0.05). However, depending on the feature, different pattern discrimination capabilities were found for the different imaging modalities.

Conclusion: The proposed phantom appears suitable for simulating heterogeneities in PET, CT, and MRI. We demonstrate that it is possible to select radiomic features for the readout of the phantom. Most of these features had been shown to be relevant in previous clinical studies.

Keywords: multi-modality imaging; physical phantom; radiomics; tumor heterogeneity.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
(a) A 3‐tube phantom filled partially with S1: 1.6‐mm diameter spheres, S2: 50% each of 1.6 and 6.3 mm, and S3: 6.3‐mm diameter spheres. H represents the homogeneous region. (b) From top to bottom: computed tomography (CT), positron emission tomography (PET), and magnetic resonance (MR) images of the phantom. (c) Examples of cancers that are represented with the proposed model; images adapted from previous reports, ,
FIGURE 2
FIGURE 2
Coefficient of variation (COV) (%) per radiomic feature across phantoms and scans for positron emission tomography (PET) (top), computed tomography (CT) (middle), and magnetic resonance imaging (MRI) (bottom). Dashed lines indicate COV ≤ 10%.
FIGURE 3
FIGURE 3
Feature values for positron emission tomography (PET) (top), computed tomography (CT) (middle), and magnetic resonance imaging (MRI) (bottom). The figure only includes those features with coefficient of variation (COV) ≤10%. Boxplots indicate the distribution of the values for homogeneous regions across phantoms and scans. The individual values (n = 4 from test/retest from both replicates) for S1, S2, and S3 are superposed on each boxplot.

References

    1. Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50:122‐150. 10.2967/jnumed.108.057307 - DOI - PMC - PubMed
    1. Harry VN, Semple SI, Gilbert FJ, Parkin DE. Diffusion‐weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol. 2008;111(2):213‐220. 10.1016/j.ygyno.2008.07.048 - DOI - PubMed
    1. Chenevert TL, Stegman LD, Taylor JMG, et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst. 2000;92:2029–2036 https://academic.oup.com/jnci/article/92/24/2029/2633587 - PubMed
    1. Padhani AR, Liu G, Mu‐Koh D, et al. Diffusion‐weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia. 2009;11(2):102‐125. 10.1593/neo.81328 - DOI - PMC - PubMed
    1. Mirnezami R, Nicholson J, Darzi A. Preparing for precision medicine. N Engl J Med. 2012;366(6):489‐491. 10.1056/NEJMp1114866 - DOI - PubMed

MeSH terms